Hepatitis News : Hep C Hospital Admissions Spike Fivefold; Those for HIV Drop by Half
A Smart + Strong Site
Subscribe to:
Hep Magazine In Bulk
Hep Newsletter
Join Us:

Back to home » Hepatitis News » October 2012


October 24, 2012

Hep C Hospital Admissions Spike Fivefold; Those for HIV Drop by Half

Rates of hospital admissions for people living with the hepatitis C virus (HCV) increased fivefold during a 15-year period, while those for people with HIV have dropped nearly 50 percent during the same span, according to a study described at the IDWeek 2012 meeting in San Diego and reported by MedPage Today. Meanwhile, hospital admission rates for people coinfected with both HIV and hepatitis C slightly more than doubled. The University of North Carolina at Chapel Hill study, whose findings are still preliminary and not yet peer-reviewed, examined the annual National Hospital Discharge Surveys from 1996 to 2010 and found 6.6 million hospital admissions coded for HCV, HIV or coinfected serostatus. Specifically, 39 percent of admissions were for HIV, 56 percent for hep C and 5 percent for coinfected patients. Because the analysis began at the advent of the antiretroviral era, HIV death rates unsurprisingly dropped, as did the rates for coinfected patients. Hep C death rates may have dropped as well, but according to Christine Oramasionwu, PharmD, PhD, of UNC-CH, this decrease was the “least pronounced.” The study’s findings are limited by the facts that they were based on retroactive observations and that the data lacked any insight into disease severity.

To read the MedPage Today article, click here.

Search: hepatitis C, hep C, HCV, hospital admissions, HIV, 1996, coinfection, Univeristy of North Carolina at Chapel Hill, death rates, IDWeek 2012, MedPage Today, National Hospital Discharge Survey, Christine Oramasionwu

Scroll down to comment on this story. Click here to visit the Hep Forums and ask questions about this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The Hep team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Quick Links
Current Issue
Hep TV
Services Directory
Conference News
Top Stories
Treatment News
Hep Exclusives
All About Hepatitis
• Hepatitis A
• Hepatitis B
• Hepatitis C
HCV/HIV Coinfection
Help Paying For Meds
Clinical Trials
Tell us what you think
Should Medicaid limit access to new hep C drugs?

Hepatitis C Reader Survey
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.